IJCRRI Journ Cur Res ReInternational Journal of Current Research and ReviewI Journ Cur Res Re2231-21960975-5241Radiance Research Academy3748http://dx.doi.org/10.31782/IJCRR.2021.131014HealthcareA Systematic Review of Relation between COVID-19 and Diabetes MankarVikrantDhengareArchanaSharmaRanjanaChakoleSwarupa190520210)170172This article is copyright of Popeye Publishing, 20092009This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.

To study compactly the general quality of the novel coronavirus (SARS-CoV-2) and provide a well understanding and treatment of the coronavirus disease (COVID-19) in persons with diabetes. Diabetes-related to incidence __ampersandsignamp; death in COVID-19 patients. Inflammation, hypercoagulation, impaired immunity can lead to increased morbidity and death. Evidence does not support the discontinuation of ACEIs, ARBs or thiazolidinediones. Chloroquine use can cause hypoglycemic events in people with diabetes and COVID-19. Inflammation, hypercoagulation, impaired immunity can lead to increased morbidity and death. Evidence does not support the discontinuation of ACEIs, ARBs Or thiazolidinediones. Chloroquine use can cause hypoglycemic events in peo ple with diabetes and COVID-19.

COVID-19 Inflammation Diabetes SARS-CoV-2